Your session is about to expire
← Back to Search
Mail and Phone Interventions for Breast Cancer Screening
N/A
Recruiting
Led By Amir Goren, PhD
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up in the 210 days following the patient's intervention send date
Awards & highlights
Study Summary
This trial compares 4 different forms of outreach to encourage mammograms among women who are due/overdue. Outreach includes postcards, letters, auto-dialer messages & live calls to see which is most effective. Interventions will be rolled out over many months.
Who is the study for?
This trial is for female members of the Geisinger Health Plan, aged 52-74, who are overdue for their annual mammogram and have been enrolled since at least October 1, 2021. Participants must be reachable by both phone and mail.Check my eligibility
What is being tested?
The study is testing four methods to encourage mammogram screening: a postcard, a letter, an automated phone message (auto-dialer), and a live call from a care team. The effectiveness of these interventions will be compared to see if any increase screening rates more than others or no outreach at all.See study design
What are the potential side effects?
Since this trial involves communication methods rather than medical treatments, there are no direct side effects related to medications or procedures. However, participants may experience inconvenience or privacy concerns with contact attempts.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ in the 210 days following the patient's intervention send date
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~in the 210 days following the patient's intervention send date
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Other outcome measures
Breast malignancy risk detected
Mammogram appointment scheduled
Mammogram completed
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Live callExperimental Treatment1 Intervention
Patients in this arm will receive a call from a Geisinger Health Plan representative noting that they're overdue for a mammogram and encouraging them to schedule (and helping them schedule if they are interested).
Group II: Formal letterExperimental Treatment1 Intervention
Patients in this arm will receive a letter from the Geisinger Health Plan (on Geisinger letterhead) noting that they're overdue for a mammogram and encouraging them to schedule.
Group III: Auto-dialerExperimental Treatment1 Intervention
Patients in this arm will receive a call from an auto-dialer with a message noting that they're overdue for a mammogram and encouraging them to schedule.
Group IV: Standard postcardActive Control1 Intervention
Patients in this arm will receive a postcard with words and an image, typical of outreach in prior years, encouraging them to schedule their annual mammograms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Letter
2020
N/A
~137510
Find a Location
Who is running the clinical trial?
Geisinger ClinicLead Sponsor
149 Previous Clinical Trials
1,868,485 Total Patients Enrolled
1 Trials studying Breast Cancer
1,342 Patients Enrolled for Breast Cancer
Amir Goren, PhDPrincipal InvestigatorGeisinger Clinic
20 Previous Clinical Trials
514,071 Total Patients Enrolled
1 Trials studying Breast Cancer
1,342 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been in hospice or receiving palliative care since January 1, 2023.I am over 66, on Medicare, and either live in an institution or have a severe illness and frailty.I have missed my yearly mammogram.I have had both of my breasts removed.I am a woman aged 52-74 and a member of the Geisinger Health Plan.
Research Study Groups:
This trial has the following groups:- Group 1: Standard postcard
- Group 2: Formal letter
- Group 3: Auto-dialer
- Group 4: Live call
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the protocol for this trial permit individuals aged 55 or above to participate?
"As indicated by the parameters for enrolment, individuals that wish to participate need to be at least 51 years old and no more than 74."
Answered by AI
Is it possible to volunteer for this experiment?
"Candidates between the ages of 51 and 74 who have been diagnosed with breast cancer are eligible for this trial which is enrolling 17650 participants."
Answered by AI
Is this trial currently enrolling participants?
"The clinical trial in question is no longer recruiting, as indicated on the clinicaltrials.gov website. Initially posted May 1st 2023 and last updated 10th of that same month; however, there are 1420 other studies currently enrolling patients at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger